首页 | 本学科首页   官方微博 | 高级检索  
检索        

血必净联合乌斯他丁治疗全身炎症反应综合征的疗效观察
引用本文:赵劲,邱一真,宋轶,胡爱浩,余凌.血必净联合乌斯他丁治疗全身炎症反应综合征的疗效观察[J].实用中西医结合临床,2010,10(1):3-4.
作者姓名:赵劲  邱一真  宋轶  胡爱浩  余凌
作者单位:1. 江苏省苏州市木渎人民医院,苏州,215101
2. 江西省武宁县中医院,武宁,332300
摘    要:目的:观察血必净联合乌斯他丁对全身炎症反应综合征的临床疗效。方法:68例全身炎症反应综合征(SIRS)患者随机分为血必净联合乌斯他丁治疗组(实验组)和乌斯他丁治疗组(对照组),治疗前和治疗后第2、4、6天观察APACHEⅡ评分、血清C反应蛋白(CRP)、凝血功能(APTT、PT、PLT等)等指标。结果:在治疗后第4、8天,实验组与对照组相比较,治疗组APACHEⅡ评分、CRP明显下降,凝血功能明显改善,具有统计学意义(P<0.05)。结论:血必净联合乌斯他丁能有效阻断SIRS病理过程,改善SIRS患者病情。

关 键 词:全身炎症反应综合征  血必净  乌斯他丁  多器官功能障碍综合征

The Clinical Therapeutic Effect of Combination Xuebinjing and Ulinastatin in Patients with Systemic Inflammatory Respose Syndrome
Zhao Jin,Qiu Yi-zhen,Song Yi,et al.The Clinical Therapeutic Effect of Combination Xuebinjing and Ulinastatin in Patients with Systemic Inflammatory Respose Syndrome[J].Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine,2010,10(1):3-4.
Authors:Zhao Jin  Qiu Yi-zhen  Song Yi  
Abstract:Objective: To evaluate the clinical therapeutic effect of combination Xuebijing and ulinastatin in patients with systemic inflammatory respose syndrome .Methods:68 patients with SIRS were randomly divided into Xuebijing combinated ulinastatin treatment group (experimental group) and ulinastatin treatment group (control group),in the different time, the APACHE Ⅱ ,the CRP of plasma and the cruor function (APTT,PLT,PT) were determined.Results: eomparised experimental group with control group ,APACHE Ⅱ and CRP were decreased and the eruor function was improved,there were significant diferences (P 〈0.05).Conelusion:Xuebijing combinated ulinastatin can interdict the patho-course of SIRS, improve curative effect of the patients with SIRS .
Keywords:Systemic inflammatory respose syndrome  Xuebijing  Ulinastatin  Multipe organ dysfunction syndrome  
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《实用中西医结合临床》浏览原始摘要信息
点击此处可从《实用中西医结合临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号